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Cancer is a major risk factor for venous thromboembolism (VTE). Its treatment is an added 
risk factor for VTE. Malignancy results in a hypercoagulable state and hence DVT requiring 
anticoagulation. Cancer patients are at high risk of anticoagulant associated bleeding. 
Bleeding complications occur more with unfractionated heparin as compared to low 
molecular weight heparin. Standard medical treatment based on vitamin K antagonists is 
less effective and is associated with increased risk of bleeding in cancer patients. Low 
molecular weight heparin treatment has added advantages such as less sensitivity to drug 
interactions, lack of need for regular monitoring and has no problem of narrow therapeutic 
window as opposed to warfarin. Gastrointestinal stromal tumours (GIST) are the most 
common mesenchymal tumours of the gastrointestinal tract. The most common 
presentation is of gastrointestinal bleeding, pain and/or dyspepsia. We report  the case of a 
67 year old hypertensive female patient who presented with a history of massive 
haematemesis and malaena. Upper gastrointestinal endoscopy confirmed a gastric tumour. 
She developed massive sudden swelling of the left lower limb whilst awaiting surgery. 
Doppler ultrasound scan confirmed an iliofemoral deep vein thrombosis (DVT). Inferior 
vena cava filter insertion was not possible due to non-availability. Coexistence of DVT 
needing anticoagulation and bleeding gastric GIST requiring urgent resection presented a 
management dilemna. Despite the risk, the patient was taken for an emergency tumor 
resection primarily to stop the bleeding and facilitate full anticoagulation therapy more 
safely. After 24 months follow up the patient had no evidence of recurrence of both the GIST 
and DVT. 
 





The risk of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and 
pulmonary embolism (PE) in cancer patients has been well recognized. Twenty percent of VTE 
events occur in people with cancer1. There are several factors that are known to influence the 
risk of VTE in cancer patients, including age, immobility, surgery and trauma2. Armand 
Trousseau was the first to describe the association between cancer and thrombosis when he 
reported cases of migratory thrombophlebitis in patients with cancer in 18673. Although 
migrating superficial thrombophlebitis (Trousseau’s Sign) and DVT have been described in 
gastric carcinoma, these are rare4.  
 
Gastric cancers commonly present with dyspepsia, vomiting, early satiety, haematemesis and 
melena. When a patient with a gastric malignancy presents with significant upper 
gastrointestinal bleeding and develops DVT whilst awaiting surgery, a management dilemma 
ensues due to the conflicting issues of hemorrhage and anticoagulation in the same patient. We 
report the case of a patient who presented with a bleeding gastrointestinal stromal tumour of 
the stomach complicated by a massive DVT. Wide resection of the tumour was done despite the 
acute DVT. Histology confirmed C- kit positive GIST. At 24 months after surgical resection, 
Imatinab and anticoagulation therapy, there was no evidence of tumour recurrence or DVT. 
ISSN 2073-9990 East Cent. Afr. J. surg. (Online)        
 
 Publication COSECSA/ASEA -East and Central African Journal of Surgery. 
August/September 2016 Volume  21  Number 2 




A 67 year old hypertensive female patient initially presented to the Physicians with a history of 
having collapsed at home following episodes of haematemesis and malaena. She admitted to 
having had weight loss and early satiety. There was no history of ingestion of non-steroidal 
inflammatory drugs (NSAIDS), alcohol or smoking.  After initial resuscitation, haemodynamic 
stabilization and upper gastrointestinal endoscopic confirmation of a bleeding gastric tumour 
by physicians, our surgical firm was consulted for surgical intervention to stop the bleeding.  
 
On examination she was pale, not jaundiced and had no significant lymphadenopathy. She had a 
grossly swollen left lower limb as illustrated in Figure 1. She had a blood pressure of 158/120 
mmHg, pulse 102 beats per minute full volume and regular, temperature 35 degrees Celsius and 
a respiratory rate of 20 breaths per minute. She had epigastric tenderness, no hepatomegaly or 
ascites and had malaena stool on digital rectal examination. All pulses were present and of 




Figure1. grossly swollen left lower limb 
 
Her full blood count showed a white cell count of 9,51micromoles per litre (4- 11), hemoglobin 
7.0 grams per deciliter (12 – 14), haematocrit of 23.7% (36- 44), mean corpuscular volume 75.7 
femtolitres (80 – 96), platelet count 261 x 103 (150 -450). Liver function tests as well as urea 
and electrolytes were normal. Total protein was 58mg/dl. International normalized ratio (INR) 
of 1.68, Activated partial thromboplastin time (APTT) 41.5 seconds (control 42.2 sec). 
 
Upper GI endoscopy done showed a mass protruding into the pyloric antrum which was soft 
and had an ulcerated surface. Biopsies were attempted but proved difficult to take. Computed 
tomography showed a mass at the gastro-duodenal junction 80X40mm axially and 60mm 
cranio-caudally (see arrows in Figure 2). Complete thrombosis of the left iliac and femoral veins, 
with thrombus protruding into Inferior vena cava (IVC) was also confirmed on CT scan  
 
A Doppler ultrasound scan of the lower limbs showed common femoral, superficial femoral, 
popliteal, peroneal, anterior and posterior tibial veins of the left lower limb were distended and 
filled with thrombi. The left common iliac and left external iliac veins were also thrombosed. 
The thrombus encroached into the IVC. Chest X-ray was normal. A diagnosis of massive ileo-
femoral DVT in a patient with a bleeding gastric tumour was made and the patient was 
commenced on low molecular weight heparin, Clexane 40mg subcuticularly once daily. 
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Figure 3a and 3b: Gastric Tumour insitu (ulcer crater) Fig 3c: after wide local excision                                     
and closure. 
 
The patient continued to bleed as evidenced by ongoing melena and hemodynamic instability. 
Anticoagulation therapy was contraindicated leaving urgent surgery as the only option to save 
life. In view of the massive DVT an Inferior vena cava filter was contemplated for possible 
deployment but was not available. Anticoagulation therapy was withheld and the patient was 
taken for an emergency laparotomy to stop the life threatening bleeding as the primary 
therapeutic goal.  
 
At laparotomy a 90 x 40 mm ulcerated tumour with a central blood clot at the gastric antrum 
was noted. This is illustrated in Figure 3a, b and c. There was no evidence of intra-abdominal 
metastatic spread and no ascites. A wide local excision of the tumour with a 2cm margin and 
preservation of the pyloric sphincter was done. The specimen was submitted for histological 
analysis and immuno-histochemistry. 
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Figure 4. Interlacing fascicles of spindle cells and epithelioid 
cells with oval nuclei and abundant basophilic cytoplasm 
characteristic of GIST. 
 
Postoperatively the patient had a nasogastric tube (NGT) inserted, intravenous fluids, analgesia 
and was continued on Clexane (EmcureR) 40mg twice daily. The NGT was removed on day 3 post 
operatively and the patient started on oral feeds.  She was also commenced on warfarin 2,5mg 
orally daily. The histological report was received on day 5 postoperative showed “a tumour 
composed of interlacing fascicles of spindle cells and epitheloid cells with oval nuclei and 
abundant basophilic cytoplasm. The cells are imbedded in collagenous stroma. Pleomorphism is 
minimal and mitosis rare. The appearance was consistent with a GIST and 
immunohistochemistry showed C-kit positive” (Figure 4). The patient was commenced on 
Imatinab 400mg orally daily indefinitely.  Our patient did not suffer pulmonary embolism and 
the left limb swelling subsided over the succeeding 4weeks. She was discharged from 




Our patient presented a management dilemma. She developed extensive DVT that required 
urgent treatment in the presence of a bleeding gastric tumour also warranting urgent surgery. 
The extent of the DVT made the risk of pulmonary embolism (PE) extremely high. Surgery in 
such circumstances would further increase the chances of a PE. Adequate anticoagulation 
therapy was hampered by the risk of increasing bleeding from the gastric tumour. Furthermore, 
the CT scan findings showed that the tumour was limited to the stomach with no evidence of 
metastases. Surgery would therefore potentially cure the bleeding and the tumour 
simultaneously. The situation was worsened by the unavailability of IVC filter that was required 
to prevent PE in the perioperative period.  
 
The major determinants of the risk of VTE in cancer patients include tumour stage, tumour type, 
chemotherapy, hormonal therapy, surgery and presence of central venous catheters4. The 
reported cumulative incidence of VTE was found to be 16 per 1000 patients in the first 2 years 
following cancer diagnoses5 and 24.6 per 1000 patients in the first year following diagnosis6. 
Our patient had notable risk factors for DVT; advanced age and female gender, gastric 
malignancy as well as immobility. There is at least 2-to 4-fold increased risk of VTE in the first 
6months after cancer diagnosis in patients with metastatic cancer compared to patients with 
limited stage cancer6. 
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Treatment of venous thromboembolism (VTE) with anticoagulation, although effective in 
patients with cancer, is fraught with higher morbidity, from bleeding and recurrent VTE, despite 
anticoagulation7. Our patient had ongoing upper GI bleeding as well DVT. Compared to patients 
without malignancy, patients with malignancy have a higher incidence of major bleeding 
ranging from 6.5 to 18 percent that is not always explained by over anticoagulation8. When 
anticoagulation is contraindicated, one treatment option is the insertion of an inferior vena cava 
filter for PE prophylaxis. This does not obviate the need for anticoagulation. Although 
retrospective cohort studies suggest lower fatality rates in some cancer patients with IVC filters, 
there are no large randomized trials in any patient population that have studied the safety and 
efficacy of vena cava filters in the treatment and prevention of VTE9. Inferior vena cava filters 
were not available at our hospital. Attempts to import from Republic of South Africa were 
unsuccessful due to prohibitive costs and unavailability at the time of need. 
 
Whilst there is abundant literature on DVT in cancer patients, there is paucity of literature on 
the occurrence and management of the contradiction of simultaneous massive DVT and massive 
bleeding from GIT tumours –clearly a rare phenomenon. Recommended initial treatment of DVT 
involves use of low molecular weight heparin eg Clexan, dalteparin. Thrombolytic therapy and 
vena caval filters should be reserved for patients in whom there is high risk of PE yet 
anticoagulation is contraindicated or insufficient9. Although the risk of PE and death was high in 
our patient undergoing emergency major surgery in the presence of massive DVT and upper GIT 
bleeding, the need to remove the cause of bleeding was compulsive. It was felt that the benefits 
of surgery far outweighed the risk. The outcome vindicated this tough and aggressive course of 
action. 
Conclusion 
A high index of suspicion for VTE is vital in cancer patients. Primary prevention of VTE by 
pharmacological agents or where contraindicated, mechanical means, is recommended in all 
cancer patients hospitalized for surgical or medical reasons. Multidisciplinary management of 
complex problems is vital. Where  DVT and the risk of VTE coexists with a life threatening 
bleeding tumour, curative surgery should not be withheld as this offers the only chance of 
survival in the absence of an IVC catheter. Whilst no major conclusions can be made on the 
successive management of this high risk case, we are encouraged to manage any future cases 
similarly and not delay lifesaving surgery under similar circumstances solely on the basis of the 
risk of PE. Only a clinical trial can resolve this issue conclusively, however this is unlikely given 
the rarity of such a clinical scenario. 
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